baber/WOPTO huggingface dataset:
Patent EP-0449373-A1 (EP)
Inventor: GUATELLI RICARDO
IPC: B65D47/06
Filed: 1991-03-26
Abstract: A security closure for containers, in particular for oil cans, comprising one single component and a collar portion (14) suitable for being applied inside an opening (13) provided through the cover (11) of a container, from which a pouring spout portion (15) extends, said collar portion (14) having a bottom wall (16) facing the interior of said can, with a lower anular lip (17) radially protruding outwards, through said bottom wall (16) two through holes (18,19) being provided, which holes are closed by portions (20,25) of tear-away material, an upper lip (23) of said collar portion (14) constraining the edge of said opening provided through the cover through an intermediate annular (24) reverse-"L"-shaped shell portion directed downwards to embrace it, with said intermediate shell portion extending from said pouring spout portion (15) and a thread-like appendix (25) being furthermore connected with an external wall of said intermediate shell portion, said thread-like appendix bearing a cap element (26) suitable for entering said collar portion above said bottom wall.
Patent EP-0442663-A1 (EP)
Inventor: SAVAGE PAUL DAVID
IPC: A61K33/244
Filed: 1991-02-06
Abstract: Certain polyoxotungstate ions, having additional atoms selected from P, transition metals and group 13 metals, and which have a metal cluster structure which is not the Keggin structure, form pharmaceutical compositions with anti-viral, especially anti-HIV, activity. Examples of compounds include those with ions of formula a), 
 
 
 
        [P₂H c W₁₂M' x O y ] P-   
 
 
 
where M' is a transition metal, x is 0 or an integer from 1 to 6, y is an integer from 48 to 62, c is 0, 1 or 2, and p is an integer dependent upon the oxidation state of the transition metal M'.
Patent EP-0448231-A1 (EP)
Inventor: BERTA NORBERT I
IPC: A61K9/28
Filed: 1991-02-22
Abstract: Improved coated medicaments and apparatus and methods of making the same are disclosed. Most preferably, products (10) are coated at each end with gelatin or other coatings. The present invention discloses products (10) having unequal coatings (12,14), as well as coatings applied to each end of a product (10) which may or may not overlap, or leave a portion (13) of the product (10) uncoated. The apparatus disclosed comprises a hopper (110) for retaining a plurality of the product (10) in a predetermined orientation, and a feeder (114) which fills a plurality of plate means (130) retaining a plurality of the product (10). The product (10) is most preferably retained in a pair of axially aligned specimens within a collet (134). The plates (130) are incrementally advanced to a first dipping means (136) and coated with a first coating material (151). After dipping, at least one of the plates (130) is preferably rotated one and one-half times. The plate (130) is then advanced to a second dipping means (140). A second rotating means (142) places the plate (130), back in its initial orientation, preferably after one and one-half revolutions. The plates (130) are then transferred by the apparatus (160) to dryer means (180) for curing the first and second coatings (12,14). After extraction from the dryer (180) coated product (10) is ejected from the plates (130). Methods of coating medicaments are also disclosed.
Patent EP-0474389-A1 (EP)
Inventor: NISHIURA YOZO
IPC: G01C19/72
Filed: 1991-08-16
Abstract: A fiber-optic gyroscope having a depolarizer (3) installed near the fiber coil (4) and a polarizer disposed in the optical path before the light is divided in two partial lights has been proposed to avoid the fluctuation of the light power passing reversely through the polarizer induced by the rotation of the polarization plane of the light. However, since the light emitting device (1) emits a linearly polarized light, the light power first passing through the polarizer will fluctuate by the rotation of the polarization plane. This invention adds another depolarizer (2) between the light emitting device (1) and the polarizer in order to reduce or eliminate such a fluctuation.
Patent EP-0484092-A1 (EP)
Inventor: BONALDO JEAN M
IPC: A61M39/14
Filed: 1991-10-29
Abstract: A medical device which prevents the backflow of fluid therethrough is particularly useful as a bloodless catheter assembly, that is, prevents the backflow of blood through the catheter by utilisation of a self-closing valve (38) carried in a hollow catheter housing (20) to one end of which a catheter (12) is fixed so as to provide a fluid passage through the catheter and catheter housing. The fluid passage in the catheter housing is sealed by a self-sealing valve element (42) extending transversely across the passage upstream from the catheter. A hollow needle (34) is held in the catheter housing downstream of and pointed at the valve element. Attachment of a fluid dispensing medical appliance to the other end of the catheter housing (20) forces the valve element (42) downstream onto the needle (34) so as to pierce the valve element and open a fluid passage from the catheter housing upstream of the valve element through the hollow needle to the catheter. Removal of the medical appliance permits the resiliently biased valve element to move upstream away from the needle, thereby resealing and thus reclosing the fluid passage which extends through the hollow needle.
Patent EP-0485155-A1 (EP)
Inventor: CRUICKSHANK KENNETH ALEXANDER
IPC: C12Q1/68
Filed: 1991-11-05
Abstract: This invention discloses methods and compounds for covalently linking nitro-, dinitro- and trinitrophenyl to DNA and the resulting nitro-, dinitro-, and trinitrophenyl labeled DNA reagents. Reagents for the  in situ  detection of a chromosome or a region of a chromosome are disclosed. These reagents include a multiplicity of DNA sequences that are complementary to different portions of the chromosome or chromosome region to be detected. Multiple nitro-, dinitro- or trinitrophenyl labels are covalently linked to the DNA sequences by means of an amino acid linking group. These labeled reagents are contacted under hybridizing conditions with the chromosome or chromosome region of interest. Any binding of the reagent with the chromosome or chromosome region of interest may then be detected by immunological techniques.
Patent EP-0493202-A1 (EP)
Inventor: HERMANT PHILIPPE
IPC: C03B13/16
Filed: 1991-12-19
Abstract: Light-scattering glazing sheet. It consists of a hot-laminated glass, the imprint impressed into the glass consisting of pyramidal craters separated from each other by distances which are smaller than their greatest dimension. In an alternative form, nonscattering areas are inserted beside the scattering regions. 
<??>The method and apparatus for producing the scattering glazing sheet also form part of the invention. 
<IMAGE>
Patent EP-0482198-A1 (EP)
Inventor: KASAI MASAHIRO
IPC: H01L39/22
Filed: 1991-02-06
Abstract: A superconductive element using an oxide superconductor which has a structure that an oxide magnetic substance is formed on an oxide superconductor via a junction interface. By utilizing a newly found proximity effect between oxide magnetic substance and oxide superconductor, and by using the oxide superconductor of short coherent length, thick superconducting element having the oxide magnetic substance can be provided.
Patent EP-0533683-A1 (EP)
Title: Device intended for measuring a dose of powdered medicament for inhalation.
Inventor: LANKINEN TAPIO
IPC: A61M15/00
Filed: 1991-04-15
Abstract: PCT No. PCT/FI91/00113 Sec. 371 Date Feb. 16, 1993 Sec. 102(e) Date Feb. 16, 1993 PCT Filed Apr. 15, 1991 PCT Pub. No. WO92/18188 PCT Pub. Date Oct. 29, 1992The invention relates to a device intended for measuring a dose of powdered medicament for inhalation, including a medicament container (1), through which extends a shaft (3) provided with at least one dosage recess (5). Container (1) is provided with at least one flap-like sweeper element (4), resting on shaft (3) in alignment with the dosage recess and having one of its ends rotatable around shaft (3), the other end of said flap dragging along the shaft surface, whereafter said shaft (3) is displaceable in this longitudinal direction relative to container (1) so as to bring dosage recess (5), along with a dose of the medicament carried therein, outside container (1). The invention relates also to the measuring of a dose of powdered medicament for inhalation by using the device described above.
Patent EP-0533714-A1 (EP)
Inventor: RAJAKALLIO PAULI
IPC: E21B19/14
Filed: 1991-06-11
Abstract: Appareil de stockage de tiges de forage (8), comprenant deux magasins de tiges de forage (7a, 7b) comprenant chacun un rotor (13a, 13b) muni de doigts de séparation, des moyens (16, 17) permettant d'introduire les tiges (8) à l'intérieur des espaces (15) formés par les doigts de séparation placés sur la circonférence du rotor (13a, 13b). Les rotors (13a, 13b) sont montés de façon qu'ils tournent en sens contraire l'un par rapport à l'autre, de telle sorte que les ergots (14) des doigts de séparation de l'un des rotors (13a, 13b) soient alignés avec les espaces (15) de l'autre rotor (13b, 13a), les tiges de forage (8) étant positionnées entre ceux-ci et déplacées alternativement par le rotor (13a, 13b) des deux magasins (7a, 7b) le long de spirales (16, 17) entourant les rotors.
Patent EP-0496895-A1 (EP)
Inventor: IIMURO SHIGERU I- - TAKIHARUCH
IPC: C07C37/20
Filed: 1991-08-15
Abstract: Procédé de préparation de bisphénol A de grande pureté, selon lequel l'on évalue en mode interactif à l'aide d'un ordinateur la composition du mélange réactionnel et la température de saturation/dissolution du bisphénol dans les conditions de la réaction, cela lorsque l'on fait réagir le phénol et l'acétone dans un réacteur du type continu ou discontinu servant à la commande automatique des conditions de la réaction ou à alimenter l'étape suivante en mélange réactionnel fluide, ledit procédé empêchant la production de cristaux de bisphénol A auxquels est ajouté du phénol et permettant une vitesse maximale de réaction à une température réduite. On peut ainsi empêcher toute fluctuation de la température de réaction et limiter la production d'impuretés. L'enlèvement facile et stable du mélange réactionnel du réacteur est assuré et empêche toute perturbation de l'étape suivante.
Patent EP-0545993-A1 (EP)
Inventor: SUDA ARATA
IPC: C23C22/38
Filed: 1991-08-23
Abstract: Un revêtement de conversion de chromate ayant d'excellentes caractéristiques d'ouvrabilité à froid et de protection contre la corrosion après peinture peut être formé sur des surfaces métalliques, en particulier sur un feuillard d'acier galvanisé, en séchant sur place sur le métal une quantité d'une composition aqueuse acide comprenant (A) de 4,0 à 51,0 g/L de chrome hexavalent; (B) de 6,0 à 38,0 g/L de chrome trivalent; (C) de 0,5 à 97,0 g/L d'ions phosphate; (D) un composant sélectionné dans le groupe comprenant les ions sulfate, les ions nitrate, les ions fluorure, et leurs mélanges; et (E) un composant sélectionné dans le groupe comprenant des cations de Cu, Co, Ni, Sn, Fe et Pb, ainsi que leurs mélanges, dans lequel le rapport pondéral entre le chrome trivalent et le chrome hexavalent est compris entre 0,2 et 1,4. De préférence la quantité de composition aqueuse utilisée est telle que la couche rapportée de chromes est comprise entre 20 et 160 mg/m2.
Patent EP-0652767-A1 (EP)
Inventor: GLUCKMAN PETER
IPC: A61K31/215
Filed: 1991-07-19
Abstract: The invention relates to the use of hGH, hGRF, hIGF-1, hIGF-2 or analogs of these or a mixture of two or more of these, alone or in conjunction with lactational enhancers for the treatment of human lactation failure. It also relates to the use of hGH, hGRF, hIGF-1, hIGF-2 or analogs of these or a mixture of two or more of these, alone or in conjunction with lactational enhancers for the manufacturing of a medicament for the treatment of human lactation failure, also a profphlactic treatment. Preferably human growth hormone is used. The invention also relates to a method for the treatment of human lactation failure as well as compositions and methods for their manufacturing.
Patent EP-0549686-A1 (EP)
Inventor: MATTEUCCI MARK
IPC: A61K31/7088
Filed: 1991-09-20
Abstract: Analogues d'oligonucléotides dans lesquels une ou plusieurs liaisons phosphodiesters entre des nucléotides adjacents sont remplacés par une liaison squelette résistant à des nucléases. Les oligonucléotides modifés sont capables d'une forte hybridation avec l'ARN ou l'ADN cible. Ces analogues d'oligonucléotides sont utiles dans des thérapies modulant l'expression de gène utilisant des oligomères de liaison spécifique "non codants" ou autres.
Patent EP-0502175-A1 (EP)
Title: Formage ameliore de plateaux presses
Inventor: BAUM GARY A
IPC: B31B50/59
Filed: 1991-09-04
Abstract: On décrit un produit (10) formé par pressage à partir d'un carton et un procédé de formage de ce produit, celui-ci comprenant une région curviligne en trois dimensions formée par pressage (20) et comprenant une structure d'amélioration de formage servant à empêcher que la direction du carton par rapport à la machine ne déforme le produit de sa forme souhaitée. Le produit en carton formé par pressage (10) comprend une paroi plane (12) dont le pourtour est au moins en partie curviligne et une paroi périphérique (14) angulaire orientée par rapport à la paroi plane (12). La région curviligne en trois dimensions formée par pressage (20) s'étend radialement vers l'extérieur à partir du pourtour curviligne de la paroi plane (12) tout en s'incurvant simultanément hors du plan défini par la paroi plane (12). La structure d'amélioration de formage comprend une ligne entaillée par écrasement (24, 25, 30, 31, 42 et 43) comportant un élément directionnel sensible s'étendant généralement parallèle à la partie curviligne (20) du pourtour de la paroi plane (12). Les lignes entaillées (24, 25, 30, 31, 42, et 43) peuvent être circulaires, sinusoïdales ou en dents de scie.
Patent EP-0539528-A1 (EP)
Inventor: COLEN WILLIAM J
IPC: E04B2/10
Filed: 1991-07-12
Abstract: Construction de mur unique (10) et élément d'espacement destiné à être utilisé par une main d'oeuvre non spécialisée dans ce type de construction. Le mur comprend de préférence une pluralité de blocs (20) agencés en couches (18a-18e) ou les uns sur les autres, chacun des blocs présentant une face extérieure (22), une face intérieure (24), une partie supérieure (26) et une partie inférieure (28), les parties supérieures et inférieures de chaque bloc présentant une gorge longitudinalle (32) alignée avec les gorges de blocs adjacents. L'élément d'espacement comprend une base supportée contre les faces intérieures de blocs adjacents, et des premier et second bras s'étendant transversalement à partir de la base et supportés contre les parties supérieures desdits blocs adjacents. Les bras sont de préférence des parties découpées de la base. Chaque bras comporte au niveau de son extrémité distale une patte (42) saillante transversalement à partir du bras et présentant des première et seconde parties (44, 46), la première partie (44) s'étendant vers le bas jusque dans la gorge d'un bloc situé au-dessous du bras, et la seconde partie (46) s'étendant vers le haut dans la gorge du bloc situé au-dessus du bras.
Patent EP-0501266-A1 (EP)
Inventor: HARMS WOLFGANG DR
IPC: C09B62/04
Filed: 1992-02-17
Abstract: Reactive dyes of the formula …<IMAGE>… in which … …  D denotes a radical of an organic dye, …  W denotes a direct bond or bridge member, …  R1 denotes H or alkyl, …  R2 denotes H or alkyl, …  R denotes H, C1-C2-alkyl, halogen or C1-C4-alkoxy, …  B denotes C2-C6-alkylene or groups which are optionally branched and/or interrupted by heteroatoms or contain heteroatoms, …  X denotes …<IMAGE>… …  Z denotes -CH=CH2, -CH2-CH2-OSO3H, -CH2-CH2-Cl, -CH2-CH2-Br, -CH2-CH2-SO3H, -CH2-CH2-O-CO-CH3, CH2-CH2-OPO3H2 or -CH2-CH2-OH, …  n denotes 1 or 2. …
Patent EP-0500026-A1 (EP)
Inventor: AUMAN BRIAN CARL
IPC: C07D491/22
Filed: 1992-02-18
Abstract: Rigid fluorine-containing compounds, monomers, and polymers based on pentacyclic core systems, such as 12H,14H-5,7-dioxapentacene of formula (I) with perfluoroalkyl and/or aryl groups in the 12, 14 positions, and 5H,12H-7,14-dioxapentacene, of formula (II) with perfluoroalkyl and/or aryl groups in the 5,12 positions. These monomers have utility in the preparation of advanced high-performance polymers, particularly polyimides. The rigid pentacyclic core decreases the coefficient of thermal expansion of the polymers, while the fluorinated substituents improve the dielectric constant and water absorption properties. Each monomer unit contains within its pentacyclic core two-O-bridges, and two -CRR f  bridges (where R is aryl, substituted aryl or perfluoroalkyl, and R f  is perfluoroalkyl).
Patent EP-0501519-A1 (EP)
Inventor: EHRENSTEIN GOTTFRIED W PROF DR
IPC: F16B25/00
Filed: 1992-02-29
Abstract: A self-tapping screw having an asymmetric thread profile has a load flank angle (6) on the flank crest (5) of up to 60 DEG  and a steep flank angle (8) on the flank crest (5) of up to 20 DEG . In this case, the load flank angle (6) increases continuously from the flank crest (5) to the root of the thread on the core diameter where it is 90 DEG . <IMAGE>
Patent EP-0506064-A1 (EP)
Inventor: GRAILLAT GERARD
IPC: A63C9/00
Filed: 1992-03-27
Abstract: The invention relates to an intermediate plate intended to be inserted between the alpine-ski binding elements and a ski. Each binding element is raised relative to the upper surface of the ski by a wedge 2, 3. One of the wedges 2 is integral with the ski, whilst the other wedge 3 is movable and guided relative to the ski for a longitudinal movement, being held against the upper surface of the ski. The wedges 2 and 3 are, moreover, connected by a narrow non-extendible link means 15. <IMAGE>
Patent EP-0506083-A1 (EP)
Inventor: NOBUE TOMOTAKA
IPC: F01N3/30
Filed: 1992-03-27
Abstract: An apparatus for regenerating a filter (10) provided to scavenge particulate which is included in exhaust gas discharged from an internal combustion engine (7). The apparatus includes a heating room (9) accommodating the filter (10), a heat-combusting device for heat-combusting the particulate scavenged by the filter (10), a microwave generating device (12) for generating a microwave to be supplied to the heating room, a slit (13) provided in a wall of the heating room (9), a microwave detecting device (14) for detecting the energy level of the microwave coupled through the slit (13), and a control section (15) for controlling the heat-combusting device.
Patent EP-0517136-A1 (EP)
Inventor: ITOH TOSHIO
IPC: B01J21/06
Filed: 1992-06-01
Abstract: A compound oxide catalyst carrier which comprises a silica-alumina or a titania-alumina and has a relative standard deviation of peak intensity of aluminum ranging from 0.100 to 0.170, as measured by scanning a cross section of a particle of the compound oxide catalyst carrier with an EPMA in a scan-line direction along a diameter-line or an approximate diameter-line of the cross section, has a moderately uniform aluminum concentration distribution in solid particles a moderate acidity and, therefore, is suitable for use as a catalyst carrier requiring attrition resistance and ability of inhibiting generation of coke or excessive cracking, such as a carrier of catalysts for production of middle distillate fractions by a suspension bed process hydrocracking of heavy oil.
Patent EP-0581979-A1 (EP)
Inventor: HUYNH-BA TUONG
IPC: C07D307/00
Filed: 1992-08-03
Abstract: 1- or 5-O-Mono- and 3,4-O-disubstituted quinic acid derivatives are prepared by reacting a derivative of a hydroxycinnamic acid, in which the hydroxyl group(s) is(are) protected, with a quinic acid derivative so as to form an ester and the protective groups are then cleaved under controlled acidity and temperature conditions. These controlled conditions make it possible to achieve a regiospecificity in the esterification and to avoid any degradation or isomerisation. The process makes possible the preparation of new quinides with a good yield.
Patent EP-0545248-A1 (EP)
Inventor: MERKEL PAUL BARRETT
IPC: G03C7/384
Filed: 1992-11-25
Abstract: A photographic element with a support and a silver halide emulsion layer includes a two-equivalent pyrazolone magenta dye-forming coupler and a heterocyclic nitrogen addendum which is a protic imidazole or a pyridine. The heterocylic nitrogen compound reduces continued coupling of two-equivalent magenta dye-forming couplers after removal from a developer solution, obviating the need for a stop bath after the development stage.
Patent EP-0559964-A1 (EP)
Inventor: BOHM GEORGE G A
IPC: B29D30/08
Filed: 1992-11-27
Abstract: A product and process for imparting decorative appliques to the sidewalls of tires during the curing operation are presented. In one embodiment, a spool (76) of applique composite material is maintained for feeding into a tire mold (70) or onto a transfer device, thereby defining a ring for vulcanization to a tire. The applique consists of a laminate received upon a carrier, the laminate having a first barrier layer (54) and a congruent second decorative layer (56). The laminate is received by a tire sidewall (64) between two grooves (66)(68) which serve to isolate the decorative layer from the tire itself. In another embodiment a laminate of white and barrier rubber stock is formed and then configured into a cylinder. A plurality of bands are cut from the cylinder then transferred to a fixture by reorienting the bands to conform to the angle of the sidewall of the tire at the point with which the band is to be adhered. The band is then transferred to a tire curing press which subsequently receives a green tire, with the band and tire being simultaneously cured, achieving a bond of the band to the tire by vulcanization.
Patent EP-0533268-A1 (EP)
Inventor: OXFORD ALEXANDER WILLIAM
IPC: C07D/
Filed: 1992-09-14
Abstract: The invention provides compounds of the general formula (I) :-
       
 or a physiologically acceptable salt or solvate thereof 
wherein 
R¹ represents a hydrogen atom or a halogen atom or a group selected from C₁₋₆alkyl and C₁₋₆alkoxy; 
R² represents a phenyl group substituted by a group selected from
       
 and optionally further substituted by one or two substituents selected from halogen atoms, C₁₋₆alkoxy, hydroxy, and C₁₋₆alkyl; 
R³ represents the group
       
 R⁴ and R⁵, which may be the same or different, each independently represent a hydrogen atom or a halogen atom or a group selected from hydroxy, C₁₋₆alkoxy and C₁₋₆alkyl; 
R⁶ represents a hydrogen atom or a group selected from -NR⁹R¹⁰ and a C₁₋₆alkyl group optionally substituted by one or two substituents selected from C₁₋₆alkoxy, hydroxy, C₁₋₆acyloxy and -SO₂R¹¹; 
R⁷, R⁸ and R⁹, which may be the same or different, each independently represent a hydrogen atom or a C₁₋₆alkyl group; 
R¹⁰ represents a hydrogen atom or a group selected from C₁₋₆alkyl, C₁₋₆acyl, benzoyl and -SO₂R¹¹; 
R¹¹ represents a C₁₋₆alkyl group or a phenyl group; 
Z represents an oxygen atom or a group selected from NR⁸ and S(O) k ; and 
k represents zero, 1 or 2. 
     The compounds may be used in the treatment or prophylaxis of depression and other CNS disorders.
Patent EP-0530999-A1 (EP)
Inventor: HUTT KENNETH WEST
IPC: B41M5/395
Filed: 1992-08-13
Abstract: A dyesheet for light-induced thermal transfer printing comprises a substrate having on one side a dyecoat comprising a polymeric binder containing at least one thermal transfer dye dissolved or dispersed therein, an absorber coat of polymeric material comprising an absorber for the inducing light, and between the dyecoat and the absorber coat an interlayer of organic polymer through which the dye molecules diffuse less readily under printing conditions than they do through the dyecoat binder.